What is LOPJLB’s current signal on ABVC?

LOPJLB’s latest quantitative signal on ABVC BioPharma, Inc. (ABVC) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is ABVC in?

ABVC BioPharma, Inc. (ABVC) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does ABVC BioPharma, Inc. (ABVC) do?

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on creating novel drugs and medical devices to address critical, underserved healthcare requirements across the United States. The company's pipeline includes several key candidates: ABV-1501, currently undergoing Phase I/II clinical trials, is being developed as a combination treatment for triple-negative breast cancer.…

Where is ABVC BioPharma, Inc. based / listed?

ABVC BioPharma, Inc. is based in US, listed on NASDAQ.

ABVC BioPharma, Inc. (ABVC) Stock · SELL · CRISIS

Key stats

Short interest · FINRA settlement 2026-07-31

Market cap: $12M
Avg volume: 125.4K
Beta: 0.54
P/E (TTM): -2.85

Short % float: 3.29%
Days to cover: 5.6
SI change: -5.0%

1W: -1.18%
1M: -26.96%
3M: -26.32%
YTD: -61.64%

vs SPY 1W: +0.01%
vs SPY 1M: -30.28%
vs SPY 3M: -28.71%
vs SPY YTD: -73.40%

Sector peers

Same-sector names ranked by LOPJLB quality proximity · Healthcare

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

ABVC BioPharma, Inc. (ABVC)

Key stats

Sector peers

Prediction markets

Company news

Congress trades

Congress trades